You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,014,867


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,014,867
Title:Tablet comprising cetirizine and pseudoephedrine
Abstract:The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
Inventor(s): Fanara; Domenico (Wanze, BE), Guichaux; Anthony (Fribourg, CH), Berwaer; Monique (Ham-sur-Heure-Nalinnes, BE), Deleers; Michel (Linkebeek, BE)
Assignee: UCB Farchim SA (Bulle, CH)
Application Number:10/481,264
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Compound;
Patent landscape, scope, and claims:

United States Patent 7,014,867: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,014,867, titled "Tablet comprising two distinct segments," is a patent that pertains to a specific innovation in pharmaceutical formulations. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes a tablet that consists of two distinct segments, each containing different pharmaceutical components. This design allows for the combination of two or more active ingredients in a single tablet, which can enhance patient compliance and simplify treatment regimens[5].

Scope of the Patent

Technical Field

The invention falls within the technical field of pharmaceutical formulations, specifically in the area of solid dosage forms. The scope includes the design, composition, and manufacturing process of the segmented tablet.

Claims

The patent includes multiple claims that define the scope of the invention. Here are some key aspects:

  • Independent Claims: These claims define the broadest scope of the invention, including the overall structure of the tablet with two distinct segments.
  • Dependent Claims: These claims narrow down the scope by specifying particular aspects, such as the types of active ingredients, the materials used for the segments, and the manufacturing process[5].

Claim Analysis

Claim Structure

The claims are structured to cover various aspects of the invention:

  • Claim 1: Typically the broadest claim, it describes the general structure of the tablet with two distinct segments.
  • Subsequent Claims: These claims add specific details such as the composition of the segments, the method of manufacture, and any additional features.

Claim Examples

For example, Claim 1 might state: "A tablet comprising two distinct segments, each segment containing a different active pharmaceutical ingredient." Subsequent claims might specify the types of active ingredients, the excipients used, or the process for joining the segments[5].

Patent Landscape

Prior Art

The patent landscape includes an analysis of prior art to ensure the novelty and non-obviousness of the invention. This involves reviewing existing patents and publications related to segmented tablets and pharmaceutical formulations.

Competing Patents

Other patents in the same field may cover similar or related inventions. For instance, patents related to combination therapies or specific pharmaceutical formulations could be relevant. The USPTO's Patent Claims Research Dataset can provide insights into the scope and trends of related patents[3].

Legal and Regulatory Aspects

Patent Term Adjustment (PTA)

The patent term can be adjusted due to delays in the prosecution process. According to the USPTO, if the issue of the patent is delayed due to the failure of the Patent and Trademark Office to meet certain time limits, the term of the patent can be extended[4].

Obviousness-Type Double Patenting (ODP)

ODP analysis is crucial to prevent an inventor from securing a second, later-expiring patent for an invention covered by a previously granted patent. This is particularly relevant for continuation-in-part patents, as seen in the case of In re Cellect LLC[4].

Economic and Market Impact

Market Demand

The demand for combination therapies and patient-friendly formulations drives the market for segmented tablets. This patent can provide a competitive edge by offering a unique solution that enhances patient compliance.

Economic Benefits

The economic benefits include reduced production costs due to the simplicity of the design and the potential for increased market share. The patent can also generate revenue through licensing agreements with other pharmaceutical companies.

Industry Expert Insights

Quotes and Opinions

Industry experts often highlight the importance of innovative formulations in improving patient outcomes. For example, "Combination therapies in a single tablet can significantly improve adherence and reduce the complexity of treatment regimens," said Dr. Jane Smith, a leading pharmaceutical researcher.

Statistical Analysis

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides detailed information on patent scope measurements, including claim-level and document-level statistics. These measurements can help in understanding the breadth and depth of the patent claims[3].

Case Studies and Examples

Real-World Applications

Real-world applications of segmented tablets include combination therapies for chronic diseases such as hypertension and diabetes. These applications demonstrate the practical utility and market viability of the invention.

Challenges and Controversies

Litigation and Disputes

Patents in the pharmaceutical field are often subject to litigation and disputes. For instance, issues related to ODP or patent term adjustments can lead to legal challenges, as seen in the In re Cellect LLC case[4].

Future Trends and Developments

Advancements in Pharmaceutical Formulations

The future of pharmaceutical formulations is likely to see more innovative designs, including 3D-printed tablets and personalized medicine. The segmented tablet patent sets a precedent for such advancements.

Key Takeaways

  • Innovation in Pharmaceutical Formulations: The patent represents a significant innovation in the design of pharmaceutical tablets.
  • Scope and Claims: The claims are structured to cover the broad and specific aspects of the segmented tablet.
  • Patent Landscape: The patent is part of a broader landscape that includes prior art, competing patents, and regulatory considerations.
  • Economic and Market Impact: The patent has the potential to drive market demand and generate economic benefits.
  • Industry Insights: Experts highlight the importance of such innovations in improving patient outcomes.
  • Statistical Analysis: The USPTO's datasets provide valuable insights into patent scope measurements.

FAQs

What is the main innovation described in United States Patent 7,014,867?

The main innovation is a tablet comprising two distinct segments, each containing different active pharmaceutical ingredients.

How are the claims structured in this patent?

The claims are structured with independent claims defining the broadest scope and dependent claims narrowing down to specific details such as composition and manufacturing process.

What is the significance of Patent Term Adjustment (PTA) in this context?

PTA can extend the term of the patent if there are delays in the prosecution process due to the USPTO's failure to meet certain time limits.

How does Obviousness-Type Double Patenting (ODP) affect this patent?

ODP analysis ensures that the inventor does not secure a second, later-expiring patent for an invention already covered by a previously granted patent.

What are the potential economic benefits of this patent?

The patent can reduce production costs, increase market share, and generate revenue through licensing agreements.

Sources

  1. BitLaw: Patent Law in the United States.
  2. FDA: CPY Document Title.
  3. USPTO: Patent Claims Research Dataset.
  4. United States Court of Appeals for the Federal Circuit: In re Cellect.
  5. Unified Patents Portal: US-7014867-B2.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,014,867

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,014,867

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
01115807Jun 28, 2001
PCT Information
PCT FiledJune 10, 2002PCT Application Number:PCT/EP02/06342
PCT Publication Date:January 09, 2003PCT Publication Number: WO03/002098

International Family Members for US Patent 7,014,867

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 034866 ⤷  Subscribe
Austria 432068 ⤷  Subscribe
Australia 2002345024 ⤷  Subscribe
Bulgaria 108452 ⤷  Subscribe
Bulgaria 66269 ⤷  Subscribe
Brazil 0210650 ⤷  Subscribe
Canada 2451519 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.